Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Mercadolibre Inc (MELI) vs GeneDx Holdings Corp (WGS) Price & Performance

Mercadolibre IncTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Mercadolibre Inc vs GeneDx Holdings Corp — how do they compare? Mercadolibre Inc trades at $1,842 (market cap $98.35B), while GeneDx Holdings Corp trades at $82.71 (market cap $2.44B). The key difference: Mercadolibre Inc is far larger — about 40.3× GeneDx Holdings Corp's market cap. Which is the better fit depends on your goals.

MELIWGS
Market Cap
$98.35B$2.44B
Sector
Consumer CyclicalTechnology
52-Week High
$2.51K$167.51
52-Week Low
$1.55K$34.51
Enterprise Value
$106.00B$2.48B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Mercadolibre Inc

MercadoLibre (MELI) trades at $1,828.29, up 0.22% with strong technical bullish signals from moving averages. The company demonstrates exceptional revenue growth, reaching $28.89 billion in 2025, though recent earnings misses and margin pressures from strategic investments have tempered investor enthusiasm. Analyst consensus remains strongly bullish with a $2,150 price target, representing 17.6% upside potential from current levels.

MELI's growth-first strategy is driving market share gains but sacrificing near-term profitability. The stock presents a compelling opportunity for long-term investors willing to tolerate margin volatility, though execution risks and competitive pressures in Latin American e-commerce warrant careful monitoring. Current valuation at 52.77 P/E reflects premium pricing for high-growth expectations.

GeneDx Holdings Corp

GeneDx Holdings Corp (WGS) trades at $82.39, up 5.79% in the past 24 hours, with a bullish technical signal and strong analyst support. The company reported Q2 2026 revenue of $114.4 million, beating guidance, and returned to adjusted profitability earlier than expected. However, net income remains negative at -$106 million for 2026, and the stock faces class action lawsuits with an August 3, 2026 deadline.

Outlook is mixed: bullish technicals and analyst consensus suggest upside to the $90 price target, but fundamental weaknesses and legal risks pose significant challenges. Investment opportunity hinges on sustained revenue growth and margin improvement, while risks include profitability pressures and litigation outcomes.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Mercadolibre Inc

MercadoLibre runs the largest e-commerce marketplace in Latin America, connecting a network of more than 140 million active users and 1 million active sellers as of the end of 2021 across an 18-country footprint. The company also operates a host of complementary businesses, with shipping solutions (Mercado Envios), a payment and financing operation (Mercado Pago), advertisements (Mercado Clics), classifieds, and a turnkey e-commerce solution (Mercado Shops) rounding out its arsenal. MercadoLibre generates revenue from final value fees, advertising royalties, payment processing, insertion fees, subscription fees, and interest income from consumer and small-business lending.

Read more on MELI

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS